Understanding and drugging RAS: 40 years to break the tip of the iceberg
Donita C. Brady(Fox Chase Cancer Center), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Julija Hmeljak(Company of Biologists)
Cited by 4
Related Papers
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
|Annual Review of Biochemistry|2011|391